Potassium Ion

Potassium Ion

SCHEMBL1273358

CC1(C)CC[C@@](C)(c2cc(F)cc(F)c2)N(CC(=O)[O-])C1=O.[K+]

nearest known ligand 0.34

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

AGTR1DHFRGABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTNR3C2PBP2XPTGS1PTGS2VKORC1blablaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAftsImrcAmrcBmrdApbp1apbp1bpbp2apbp2bpbp3polthyA

The experimentally established mechanism targets of Potassium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
CALCRL Q16602 7/20 0.34
RAMP1 O60894 2/20 0.34
HCAR3 P49019 1/20 0.34
HCAR2 Q8TDS4 1/20 0.34
RAMP3 O60896 1/20 0.33
CALCR P30988 1/20 0.33
PER2 O15055 2/20 0.31
CRY2 Q49AN0 2/20 0.31
APP P05067 1/20 0.30
BACE1 P56817 1/20 0.30
METAP2 P50579 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Potassium Ion SCHEMBL5670572 1.00 CALCRL (0.34) CALCRLRAMP1HCAR3HCAR2RAMP3
SCHEMBL3592769 0.87 HCAR3 (0.38) CALCRLRAMP1HCAR3HCAR2RAMP3
SCHEMBL12901354 0.87 HCAR3 (0.38) CALCRLRAMP1HCAR3HCAR2RAMP3
SCHEMBL12901358 0.84 CALCRL (0.35) CALCRLRAMP1HCAR3HCAR2RAMP3
SCHEMBL12936529 0.84 CALCRL (0.35) CALCRLRAMP1HCAR3HCAR2RAMP3
SCHEMBL1273412 0.71 HCAR2 (0.38) CALCRLHCAR3HCAR2PER2CRY2
Lithium Ion SCHEMBL977109 0.70 CALCRL (0.38) CALCRLRAMP1RAMP3CALCR
SCHEMBL12921066 0.69 CALCRL (0.34) CALCRLRAMP1HCAR3HCAR2RAMP3
SCHEMBL1274621 0.68 CALCRL (0.58) CALCRLRAMP1
SCHEMBL12921051 0.64 CALCRL (0.53) CALCRLRAMP1RAMP3CALCR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7893079-B2 Substituted monocyclic CGRP receptor antagonists MERCK SHARP & DOHME CORP. (US) 2011-02-22 US disclosed
US-20070265225-A1 Substituted monocyclic CGRP receptor antagonists MERCK SHARP & DOHME LLC 2007-11-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070265225-A1 Substituted monocyclic CGRP receptor antagonists QRFPR, CALCRL, EDNRB CALCRL 2/4885RAMP1 70/4885HCAR3 111/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.